Clinical trial
Precision Medical Research of Non-immune Fetal Hydrops (NIFH)-From Prenatal Diagnosis to Intrauterine Treatment
NCT02956564 is registered in ClinicalTrials.gov with Shanghai First Maternity and Infant Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Precision Medical Research of Non-immune Fetal Hydrops (NIFH)-From Prenatal Diagnosis to Intrauterine Treatment
- Lead sponsor
- Shanghai First Maternity and Infant Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 31, 2016
- Completion date
- August 31, 2018
- Enrollment
- 144 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
fetal hydrops